RayzeBio inc (DELISTED) (RYZB:DL)
62.49
0.00 (0.00%)
USD |
NASDAQ |
Mar 06, 16:00
RayzeBio Cash and Short Term Investments (Quarterly): 540.17M for Sept. 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 540.17M |
| June 30, 2023 | 256.95M |
| Date | Value |
|---|---|
| December 31, 2022 | 296.25M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
256.95M
Minimum
Jun 2023
540.17M
Maximum
Sep 2023
364.46M
Average
296.25M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 9.67B |
| Karuna Therapeutics Inc (DELISTED) | 1.263B |
| Ambrx Biopharma Inc (DELISTED) | 225.26M |
| Pfizer Inc | 11.93B |
| Mirati Therapeutics Inc (DELISTED) | 976.43M |